Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma

BACKGROUND: EGFR mutation is a common oncogene driver in East Asians with lung adenocarcinoma (LUAD), conferring a favorable prognosis with effective targeted therapy. However, the EGFR mutation is a weak predictor of long-term survival. Therefore, a powerful predictive tool is urgently needed to es...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chengming, Zheng, Sufei, Wang, Sihui, Wang, Xinfeng, Feng, Xiaoli, Sun, Nan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040386/
https://www.ncbi.nlm.nih.gov/pubmed/33889215
http://dx.doi.org/10.1177/17588359211006949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040386/
https://www.ncbi.nlm.nih.gov/pubmed/33889215
http://dx.doi.org/10.1177/17588359211006949

Ejemplares similares